Skip to main content
Top
Published in: Strahlentherapie und Onkologie 12/2022

Open Access 25-04-2022 | Care | Original Article

Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study

Authors: Alexander Fabian, MD, MBA, Justus Domschikowski, Wolfgang Greiner, Gunnar Bockelmann, Elias Karsten, Alexander Rühle, Nils H. Nicolay, Anca L. Grosu, Jürgen Dunst, David Krug

Published in: Strahlentherapie und Onkologie | Issue 12/2022

Login to get access

Abstract

Purpose

Financial toxicity arises in cancer patients from subjective financial distress due to objective financial burden from the disease or treatment. Financial toxicity associates with worse outcomes. It has not been described in cancer patients undergoing radiotherapy in Germany and its publicly funded health system. In this context, we therefore investigated the prevalence of financial toxicity, associated risk factors, and patient preferences on communication of financial burden.

Methods

We conducted a preregistered (https://​doi.​org/​10.​17605/​OSF.​IO/​KH6VX) cross-sectional study surveying patients at the end of their course of radiotherapy in two institutions. Objective financial burden was assessed by direct costs and loss of income. Financial toxicity was measured by subjective financial distress per EORTC QLQ-C30. We used Spearman’s correlation and Fisher’s exact test for univariate analysis, an ordinal regression for multivariate analysis. A p-value < 0.05 was considered statistically significant.

Results

Of the 100 patients participating in the study, 68% reported direct costs, 25% loss of income, and 31% subjective financial distress. Per univariate analysis, higher subjective financial distress was significantly associated with active employment, lower quality of life, lower household income, higher direct costs, and higher loss of income. The latter three factors remained statistically significant in the multivariate analysis. A relative majority of the patients welcomed communication regarding financial burden with their radiation oncologist.

Conclusion

Financial toxicity is prevalent in cancer patients treated with radiotherapy in Germany. The reported risk factors may help to identify patients at risk. Future studies should validate these results and investigate interventions for financial toxicity to potentially improve outcomes.
Appendix
Available only for authorised users
Literature
15.
go back to reference Fayers P, Aaronson NK, Bjordal K et al (2001) EORTC QLQ-C30 scoring manual, 3rd edn. European Organisation for Research and Treatment of Cancer, Brussels Fayers P, Aaronson NK, Bjordal K et al (2001) EORTC QLQ-C30 scoring manual, 3rd edn. European Organisation for Research and Treatment of Cancer, Brussels
Metadata
Title
Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study
Authors
Alexander Fabian, MD, MBA
Justus Domschikowski
Wolfgang Greiner
Gunnar Bockelmann
Elias Karsten
Alexander Rühle
Nils H. Nicolay
Anca L. Grosu
Jürgen Dunst
David Krug
Publication date
25-04-2022
Publisher
Springer Berlin Heidelberg
Keywords
Care
Radiotherapy
Published in
Strahlentherapie und Onkologie / Issue 12/2022
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-022-01936-z

Other articles of this Issue 12/2022

Strahlentherapie und Onkologie 12/2022 Go to the issue